ARTYKUŁ PRZEGLĄDOWY
The anthracycline cardiotoxicity
Marek Wojtukiewicz , Joanna Omyła , L Kozłowski 1 , Beata Szynaka
1. Onkologii Akademii Medycznej w Białymstoku.
Opublikowany: 2000-07-15
GICID: 01.3001.0000.3290
Dostępne wersje językowe: en
Wydanie: Postepy Hig Med Dosw 2000; 54 (4)
Abstrakt
The anthracyclines are among the most active and useful anticancer agents, but they are also the most common chemotherapeutics associated with the development of congestive heart failure. Twenty seven to sixy percent of patients with anthracycline-induced cardiomyopathy die of congestive cardiac failure. The paper presents the pathomechanisms of anthracycline-induced cardiotoxicity and perspectives on prevention of congestive heart failure resulting from anthracycline chemiotherapy.